Crossmark Global Holdings, Inc. Takeda Pharmaceutical CO LTD Transaction History
Crossmark Global Holdings, Inc.
- $5.49 Billion
- Q4 2024
A detailed history of Crossmark Global Holdings, Inc. transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Crossmark Global Holdings, Inc. holds 210,484 shares of TAK stock, worth $2.8 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
210,484
Previous 54,689
284.87%
Holding current value
$2.8 Million
Previous $778,000
258.23%
% of portfolio
0.05%
Previous 0.01%
Shares
20 transactions
Others Institutions Holding TAK
# of Institutions
331Shares Held
73.6MCall Options Held
1.96MPut Options Held
165K-
Capital Research Global Investors Los Angeles, CA13.1MShares$175 Million0.04% of portfolio
-
Morgan Stanley New York, NY5.35MShares$71.3 Million0.01% of portfolio
-
Mondrian Investment Partners LTD London, X05.09MShares$67.9 Million1.21% of portfolio
-
Arrowstreet Capital, Limited Partnership Boston, MA4.64MShares$61.7 Million0.05% of portfolio
-
Goldman Sachs Group Inc New York, NY4.56MShares$60.7 Million0.01% of portfolio
About TAKEDA PHARMACEUTICAL CO LTD
- Ticker TAK
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 3,109,050,112
- Market Cap $41.4B
- Description
- Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...